Semaglutide, the active ingredient in Ozempic and Wegovy, is a groundbreaking medication for treating type 2 diabetes and obesity. Backed by extensive clinical research, semaglutide offers a wide range...
River Oaks / Bellaire Beauty and Weight Loss Center
We offer the very best personalized care to help you achieve optimal health, beauty and wellness. We bring together traditional medicine with clinically proven strategies from natural “bio-identical” hormone replacement therapy, nutrition and weight-loss to non-invasive medical aesthetic procedures. Our program will help you achieve your personal goals of enhancing your natural image. Explore the key categories of services we offer to our esteemed clients below.
Weight Loss Managment
Supervised Medical Weight Loss Program
Unlock a new chapter in your weight management journey with Our medically superwised Weight Loss Program. We offer several weight loss treatments each customized for the individual patient. These medically prescribed treatments are designed to boost metabolism curb appetite and help reduce stubborn fat deposit . It’s an ideal solution for those seeking effective, long lasting weight loss without the need for invasive procedures.
Medications used such as GLP1/GIP agonist ( under brand name Ozempic. Wegovy, Zepbound, Mounjaro), Phentermine, Phendimetrazin, Tenuate, Didrex, Contrave, Qsymia and HCG work harmoniously with your body’s natural processes, ensuring a safe approach to achieving your desired body shape. By focusing on natural body contouring, this treatment not only aids in weight loss but also enhances your overall well-being. It’s a seamless integration into your lifestyle, offering a hassle-free path to a healthier, more confident you.
Main Services
Skin Solutions
Explore articles and stay connected
Read More
Semaglutide: A New Weapon in the Fight Against Obesity The global obesity crisis demands innovative solutions. Enter semaglutide, a medication originally designed for type 2 diabetes, that’s showing promise...
Tirzepatide Shows Promise for Weight Loss After Solid Organ Transplants: Study Presented at ADA 2024
Exciting news emerged from the recent American Diabetes Association (ADA) 2024 conference regarding Tirzepatide, a medication gaining traction for weight management. A published abstract in the journal Diabetes® explored...